GSK
823 hedge funds and large institutions have $9.91B invested in GSK in 2023 Q2 according to their latest regulatory filings, with 80 funds opening new positions, 291 increasing their positions, 275 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more capital invested
Capital invested by funds: $9.66B → $9.91B (+$246M)
0.13% more ownership
Funds ownership: 6.66% → 6.79% (+0.13%)
15% less funds holding in top 10
Funds holding in top 10: 13 → 11 (-2)
Holders
823
Holding in Top 10
11
Calls
$207M
Puts
$133M
Top Buyers
| 1 | +$197M | |
| 2 | +$67.7M | |
| 3 | +$64.2M | |
| 4 |
Morgan Stanley
New York
|
+$63.8M |
| 5 |
Holocene Advisors
New York
|
+$61.8M |
Top Sellers
| 1 | -$105M | |
| 2 | -$93.8M | |
| 3 | -$56.1M | |
| 4 |
Renaissance Technologies
New York
|
-$43M |
| 5 |
Goldman Sachs
New York
|
-$35.8M |